Investigating plasma volume expanders as novel macromolecular MRI-CEST contrast agents for tumor contrast-enhanced imaging

被引:8
|
作者
Consolino, Lorena [1 ,4 ]
Irrera, Pietro [1 ,2 ]
Romdhane, Feriel [1 ]
Anemone, Annasofia [1 ]
Longo, Dario Livio [3 ]
机构
[1] Univ Turin, Mol Imaging Ctr, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[2] Univ Campania Luigi Vanvitelli, Caserta, Italy
[3] Natl Res Council Italy CNR, Inst Biostruct & Bioimaging IBB, Via Nizza 52, I-10126 Turin, Italy
[4] Rhein Westfal TH Aachen, Inst Expt Mol Imaging, Dept Nanomed & Theranost, Aachen, Germany
基金
欧盟地平线“2020”;
关键词
chemical exchange saturation transfer; gadolinium; macromolecular agent; magnetic resonance imaging; plasma volume expander; SATURATION-TRANSFER MRI; IN-VIVO; DCE-MRI; VASCULAR-PERMEABILITY; DENTATE NUCLEUS; BLOOD-POOL; EXCHANGE; ALBUMIN; BINDING; DELIVERY;
D O I
10.1002/mrm.28778
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of this study was to investigate two clinically approved plasma volume expanders (dextran 70 and voluven) as macromolecular MRI-chemical exchange saturation transfer (CEST) contrast agents to assess tumor vascular properties. Methods: CEST contrast efficiency of both molecules (6% w/v) was measured in vitro at various irradiation saturation powers (1-6 mu T for 5 s) and pH values (range, 5.5-7.9) and the exchange rate of hydroxyl protons was calculated. In vivo studies in a murine adenocarcinoma model (n = 4 mice for each contrast agent) upon i.v. injection provided CEST-derived perfusion tumor properties that were compared with those obtained with a gadolinium-based blood-pool agent (Gd-AAZTA-Madec). Results: In vitro measurements showed a marked CEST contrast dependency to pH, with higher CEST contrast at lower pH values for both molecules. The measured prototropic exchange rates confirmed a base-catalyzed exchange rate that was faster for dextran 70 in comparison to voluven. Both molecules showed a similar CEST contrast increase (Delta ST% > 3%) in the tumor tissue up to 30 min postinjection, with heterogeneous accumulation. In tumors receiving both CEST and T1-weighted agents, a voxel-by-voxel analysis indicated moderate spatial correlation of perfusion properties between voluven/dextran 70 and Gd-AAZTA-Madec, suggesting different distribution patterns according to their molecular size. Conclusions: The obtained results showed that both voluven and dextran 70 can be exploited as MRI-CEST contrast agents for evaluating tumor enhancement properties. Their increased accumulation in tumors and prolonged contrast enhancement promote their use as blood-pool MRI-CEST agents to examine tumor vascularization.
引用
收藏
页码:995 / 1007
页数:13
相关论文
共 50 条
  • [31] Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice
    de Lussanet, QG
    Langereis, S
    Beets-Tan, RGH
    van Genderen, MHP
    Griffioen, AW
    van Engelshoven, JMA
    Backes, WH
    RADIOLOGY, 2005, 235 (01) : 65 - 72
  • [32] Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging
    Yan Ling Wen
    Masatoshi Kudo
    Yasunori Minami
    Hobyung Chung
    Yoichiro Suetomi
    Hirokazu Onda
    Masayuki Kitano
    Toshihiko Kawasaki
    Kiyoshi Maekawa
    Journal of Medical Ultrasonics, 2003, 30 (3) : 141 - 151
  • [33] Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast
    Hawighorst, H
    Schreiber, W
    Knopp, MV
    Essig, M
    EngenhartCabilic, R
    Brix, G
    vanKaick, G
    MAGNETIC RESONANCE IMAGING, 1996, 14 (10) : 1119 - 1126
  • [34] CONTRAST-ENHANCED MRI OF TUMORS - COMPARISON OF GD-DTPA AND A MACROMOLECULAR AGENT
    WIKSTROM, MG
    MOSELEY, ME
    WHITE, DL
    DUPON, JW
    WINKELHAKE, JL
    KOPPLIN, J
    BRASCH, RC
    INVESTIGATIVE RADIOLOGY, 1989, 24 (08) : 609 - 615
  • [35] Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI
    Pauls, Sandra
    Mottaghy, Felix M.
    Schmidt, Stefan A.
    Krueger, Stefan
    Moeller, Peter
    Brambs, Hans-Juergen
    Wunderlich, Arthur
    MAGNETIC RESONANCE IMAGING, 2008, 26 (10) : 1334 - 1341
  • [36] DETECTION OF ZONAL RENAL ISCHEMIA WITH CONTRAST-ENHANCED MR IMAGING WITH A MACROMOLECULAR BLOOD POOL CONTRAST AGENT
    VEXLER, VS
    BERTHEZENE, Y
    CLEMENT, O
    MUHLER, A
    ROSENAU, W
    MOSELEY, ME
    BRASCH, RC
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1992, 2 (03): : 311 - 319
  • [37] Comparative analysis of dynamic contrast-enhanced MRI, dynamic contrast-enhanced CT, and their combination for adrenal tumor diagnosis in men
    Yan, Minghui
    Wang, Yanan
    Jiao, Lianghong
    JOURNAL OF MENS HEALTH, 2024, 20 (07) : 113 - 119
  • [38] Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media
    H. Daldrup
    David M. Shames
    Michael Wendland
    Yoshitaka Okuhata
    Thomas M. Link
    Werner Rosenau
    Ying Lu
    R. C. Brasch
    Pediatric Radiology, 1998, 28 : 67 - 78
  • [39] Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media
    Daldrup, H
    Shames, DM
    Wendland, M
    Okuhata, Y
    Link, TM
    Rosenau, W
    Lu, Y
    Brasch, RC
    PEDIATRIC RADIOLOGY, 1998, 28 (02) : 67 - 78
  • [40] Contrast-enhanced MR imaging of pulmonary arteries: new imaging strategies using different contrast agents
    Marcus R Makowski
    Andrea J Wiethoff
    Vicky Parish
    Aaron Bell
    Rene M Botnar
    Christian Jansen
    Sergio Uribe
    Martin Rohrer
    Reza Razavi
    Tobias Schaeffter
    Gerald F Greil
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)